For research use only. Not for therapeutic Use.
BRD4-IN-4 (Compound 1) is a BRD4 inhibitor (IC50=6.83 μM). BRD4-IN-4 selectively inhibits MV4-11 cell line proliferation and arrests cell at G1 phase. BRD4-IN-4 can be used for research of MLL leukemia[1].
| Catalog Number | I041078 |
| CAS Number | 304685-40-3 |
| Synonyms | 1-ethyl-6-pyrrolidin-1-ylsulfonylbenzo[cd]indol-2-one |
| Molecular Formula | C17H18N2O3S |
| Purity | ≥95% |
| InChI | InChI=1S/C17H18N2O3S/c1-2-19-14-8-9-15(23(21,22)18-10-3-4-11-18)12-6-5-7-13(16(12)14)17(19)20/h5-9H,2-4,10-11H2,1H3 |
| InChIKey | HTONIJRZZRKKQF-UHFFFAOYSA-N |
| SMILES | CCN1C2=C3C(=C(C=C2)S(=O)(=O)N4CCCC4)C=CC=C3C1=O |
| Reference | [1]. Feng Y, et al. Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors. Eur J Med Chem. 2018 May 25;152:264-273. |
